Innoviva, Inc. (NASDAQ:INVA – Get Rating) was the recipient of a significant increase in short interest in May. As of May 31st, there was short interest totalling 9,930,000 shares, an increase of 10.7% from the May 15th total of 8,970,000 shares. Based on an average daily trading volume, of 688,200 shares, the days-to-cover ratio is […]
Innoviva (NASDAQ:INVA – Get Rating) and Cogent Biosciences (NASDAQ:COGT – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk. Analyst Ratings This is a summary of current recommendations for […]
Cogent Biosciences (NASDAQ:COGT – Get Rating) and Innoviva (NASDAQ:INVA – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk. Valuation & Earnings This table compares Cogent Biosciences and Innoviva’s […]
Innoviva, Inc. (NASDAQ:INVA – Get Rating) major shareholder Alexander J. Denner acquired 7,000 shares of the business’s stock in a transaction dated Monday, June 5th. The shares were bought at an average price of $13.04 per share, for a total transaction of $91,280.00. Following the acquisition, the insider now owns 7,207,000 shares of the company’s […]
Innoviva, Inc. , a diversified holding company with a portfolio of royalties and other healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will present at the Goldman. | June 6, 2023